GILEAD: Data on 53 Patients Treated with investigational antiviral Remdesivir through the compassionate use program published in New England Journal of Medicine

PRESS RELEASE
Data on 53 Patients Treated With Investigational Antiviral Remdesivir Through the Compassionate Use Program Published in New England Journal of Medicine
April 10, 2020 at 3:31 PM EDT
— Remdesivir treatment resulted in clinical improvement in 68 percent of patients in this limited data set —
FOSTER CITY, Calif.–(BUSINESS WIRE)–Apr. 10, 2020– Gilead Sciences, Inc. (Nasdaq: GILD) today announced results from a cohort analysis of 53 patients hospitalized with severe complications of COVID-19 who …

The post GILEAD: Data on 53 Patients Treated with investigational antiviral Remdesivir through the compassionate use program published in New England Journal of Medicine appeared first on The Loadstar.

Source: The Loadstar

Be the first to comment on "GILEAD: Data on 53 Patients Treated with investigational antiviral Remdesivir through the compassionate use program published in New England Journal of Medicine"

Geef een reactie

Het e-mailadres wordt niet gepubliceerd. Vereiste velden zijn gemarkeerd met *

*